Skip to main content

Latest SEC Filings — Page 185

Page 185 · 30 filings scored 7+ · newest 9:29 AM ET · How scores work

Thu, Aug 1330 filings
7EWSBEWSB Bancorp, Inc.Investment Advisor Hope Lundt Discloses 9.93% Stake and Board AppointmentSchedule 13D · Ownership stake● Neutral7ODYSOdysight.ai Inc.Odysight.ai Secures First Boeing Order as Backlog Climbs to $16.45MForm 8-K · Current report▲ Positive7BORRBorr Drilling LtdBorr Drilling Q2 2026: Net Loss Widens to $241M on Refinancing Costs; Adjusted EBITDA Falls 50%Form 6-K · Current report▼ Negative8CYTKCytokinetics, IncorporatedCytokinetics Sues Bristol-Myers Squibb Over MYQORZO PatentForm 8-K · Current report▼ NegativePro8BTBTBit Digital, IncBit Digital Q2: $32.1M Revenue, $540M New Cloud Contracts, $1B BacklogForm 8-K · Current report▲ PositivePro7ODYSOdysight.ai Inc.Odysight.ai Q2 Revenue Up 16% but H1 Loss Widens; Cash Burn AcceleratesForm 10-Q · Periodic report▼ Negative8ISSCINNOVATIVE SOLUTIONS & SUPPORT INCISSC Q3 Earnings Beat: Revenue Up 11%, Adjusted EPS $0.33 vs $0.22 EstimateForm 8-K · Current report▲ PositivePro7UHSUniversal Health Services, Inc.UHS Finalizes $1.1B Senior Secured Notes Offering to Refinance 2026 MaturityForm 8-K · Current report● Neutral7WBIWaterBridge Infrastructure LLCWaterBridge Launches $100M Senior Notes Offering to Repay RevolverForm 424B3 · Offering● Neutral7UHSUniversal Health Services, Inc.UHS Finalizes $1.1B Senior Secured Notes Offering to Refinance Debt and Fund TalkspaceForm 424B5 · Offering● Neutral7BANRBanner CorporationBanner Corp–Pacific Financial Merger Clears State and FDIC HurdlesForm 8-K · Current report▲ Positive7WBIWaterBridge Infrastructure LLCWaterBridge Launches $100M Senior Notes Offering to Repay RevolverForm 8-K · Current report● Neutral7CHCIComstock Holding Companies, Inc.Comstock Q2 2026: Revenue +74% to $22.6M, Net Income $8.8M Driven by Jericho Mark-to-Market GainForm 10-Q · Periodic report▲ Positive7FFAIFaraday Future Intelligent Electric Inc.Faraday Future Shareholders Approve $25M Convertible Note Conversion, Reject Name ChangeForm 8-K · Current report▼ Negative8ADCTADC Therapeutics SAFDA Raises Substantial Concerns on LOTIS-5 Benefit-Risk; ADC Therapeutics Evaluates Regulatory PathForm 8-K · Current report▼ NegativePro8UMEWUMeWorld Inc.UMeWorld Q3 Revenue Jumps to $540K but Going Concern Warning PersistsForm 10-Q · Periodic report▼ NegativePro7LIVELIVE VENTURES IncLive Ventures Q3 Loss Widens on Retail-Flooring Weakness; Cash Availability $39.8MForm 8-K · Current report▼ Negative7CHCIComstock Holding Companies, Inc.Comstock Q2 Revenue Jumps 74% to $22.6M; Net Income Up 512%Form 8-K · Current report▲ Positive7SINTSintx Technologies, Inc.Sintx Clears Nasdaq Hurdle, Delisting Threat LiftedForm 8-K · Current report▲ Positive7CRNTCeragon Networks Ltd.Ceragon Extends Credit Facility to 2028, Relaxes Covenants, and Discloses New LitigationForm 6-K · Current report▼ Negative8RMXIRMX Industries, Inc.RMX Industries Reports First Commercial Revenue, $17.1M Net Loss, and Going Concern WarningForm 10-Q · Periodic report▼ NegativePro8POETPOET Technologies Inc.POET Technologies Q2 Revenue Up 112%, Loss Narrows, $50M Lumilens OrderForm 6-K · Current report▲ PositivePro7LWAYLifeway Foods, Inc.Lifeway Q2 Sales Jump 24% but Profit Plunges 97% on Milk CostsForm 10-Q · Periodic report▼ Negative9CYABCyabra, Inc.Cyabra Q2 Loss Widens, Going Concern Warning Reiterated; $6M Offering ClosedForm 10-Q · Periodic report▼ NegativePro7RENXRenX Enterprises Corp.RenX Posts Record Q2 Revenue of $4.26M, Logistics Turns Profitable AgainForm 8-K · Current report▲ Positive7LWAYLifeway Foods, Inc.Record Q2 Sales of $66.9M for Lifeway Foods, but Margin Compression Erodes ProfitForm 8-K · Current report● Neutral7AETNAETERNUM HEALTH, INC.Aeternum Pays 50M Shares for Option on 51% of Nkamouna Cobalt-Nickel ProjectForm 8-K · Current report● Neutral8GLNGGolar LNG LtdGolar LNG Q2 2026: Net Income Up 145%, Fourth FLNG Ordered, $600M RCF ClosedForm 6-K · Current report▲ PositivePro7DWTXDogwood Therapeutics, Inc.Dogwood Q2 Loss Widens on $6.7M Impairment; Halneuron Phase 2b Topline Data on Track for FallForm 8-K · Current report● Neutral8CINGCingulate Inc.Cingulate Q2 10-Q: $28.4M Cash, Going Concern Doubt, FDA CRL DetailsForm 10-Q · Periodic report▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.